Are Nicotine Analogs Taxable? Why Product Definitions Matter

Nicotine products are evolving faster than many tax processes can keep up.

Nicotine analogs are one example. Although these substances are chemically different from nicotine, they may have a substantially similar chemical structure or produce a similar effect on the central nervous system.

That difference can create a complicated tax question: Is a product taxable if it contains a nicotine analog but does not technically contain nicotine?

The answer depends on the jurisdiction.

Some states explicitly include nicotine analogs in their definitions of nicotine, alternative nicotine products, oral nicotine products, vapor products, or other tobacco products. Others use broader product definitions that may require additional analysis.

For manufacturers, distributors, wholesalers, and retailers, the risk is assuming that a product is not taxable simply because it does not contain traditional tobacco-derived or synthetic nicotine.

Nicotine Analogs Are Not the Same as Synthetic Nicotine

Tobacco-derived nicotine and synthetic nicotine are chemically nicotine. Their primary difference is how they are produced.

A nicotine analog is a different substance. State definitions commonly describe it as a substance that:

  • Has a chemical structure substantially similar to nicotine; or
  • Produces an effect on the central nervous system substantially similar to, or greater than, the effect of nicotine.

That distinction matters because excise tax laws depend heavily on statutory definitions. If a jurisdiction specifically includes nicotine analogs within its definition of “nicotine” or a taxable product category, the product may create tax, licensing, recordkeeping, and reporting obligations.

States Are Expanding Their Product Definitions

Several states demonstrate how differently nicotine analogs can be addressed.

For example:

  • Nebraska includes nicotine analogues in its definitions of both alternative nicotine products and electronic nicotine delivery systems. Beginning January 1, 2026, alternative nicotine products, including those containing analogues, became subject to the state’s Tobacco Products Tax Act. Review the Nebraska definitions and Department of Revenue guidance.
  • Oregon specifically includes nicotine analogs in its definition of an oral nicotine product. Effective January 1, 2026, qualifying products became subject to a per-package or per-unit tax. Review Oregon Revised Statutes Chapter 323.
  • Illinois defines nicotine broadly to include salts, complexes, nicotinic alkaloids, and nicotine analogs. That definition feeds into the state’s tobacco products tax requirements. Review the Illinois Tobacco Products Tax Act.
  • Iowa enacted legislation that will explicitly add nicotine analogs to its alternative nicotine and vapor product definitions beginning January 1, 2027. The change also introduces tax, licensing, electronic reporting, and recordkeeping requirements for those products. Review Iowa Senate File 2480.
  • Utah includes nicotine analogs within its definition of nicotine. The applicable tax treatment then depends on whether the item qualifies as a pouch, another alternative nicotine product, an electronic cigarette product, or a nontherapeutic nicotine product. Review the Utah definition and Utah Tax Bulletin 10-26.
  • Vermont includes nicotine analogs within the definitions of other tobacco products and new smokeless tobacco. The applicable tax calculation depends on which category applies to the product. Review Vermont’s product definitions.

These examples illustrate the larger challenge: There is no single nationwide taxability rule for nicotine analog products.

Product Classification Drives the Tax Result

Correctly taxing an evolving nicotine product requires more than identifying one ingredient. The applicable rule may depend on:

  • Whether the product contains nicotine, or a nicotine analog;
  • Whether it is intended for oral consumption, inhalation, or another use;
  • Whether it is a pouch, liquid, device, cartridge, lozenge, or another product form;
  • The number of units in a package;
  • Net weight or liquid volume;
  • Wholesale price, manufacturer’s sales price, purchase price, or actual cost;
  • Whether the product qualifies for an FDA-related exclusion; and
  • When the jurisdiction’s definition or rate became effective.

A single product may require a percentage-of-price calculation in one state, a per-package calculation in another, and a per-milliliter or per-unit calculation somewhere else.

That makes nicotine analog taxability a product-data and tax-logic challenge, not just as easy as looking up a rate.

Why Manual Tax Processes Create Risk

When taxability is managed through spreadsheets or static product mappings, tax teams must manually track:

  • New and amended product definitions;
  • Effective dates;
  • Product classifications;
  • Jurisdiction-specific tax bases and rates;
  • Filing schedules; and
  • Changes to forms and electronic filing requirements.

That process becomes difficult to control and to ensure accurate tax compliance across multiple jurisdictions.

A product categorized incorrectly during tax determination can carry that error through the entire compliance process. The business may underpay or overpay tax, report the transaction on the wrong schedule, or discover the issue only after filing.

How Businesses Can Prepare for Nicotine Analog Tax Requirements

Tax teams should take several steps as nicotine analog products enter their catalogs.

  1. Identify Nicotine Analogs in Product Data
    Do not group nicotine analogs together with tobacco-derived or synthetic nicotine without further analysis. Maintain enough information to distinguish the substance and the product’s intended method of consumption.
  2. Capture the Attributes That Drive Taxability
    Product records may need to include package count, individual units, volume, weight, product form, price, cost, FDA status, and other jurisdiction-specific attributes.
  3. Apply Jurisdiction-Specific, Effective-Dated Logic
    Tax rules should account for the definition, category, rate, and effective date that apply in each jurisdiction. Iowa’s January 1, 2027 change is one example of why future-dated rules also need to be managed before they take effect.
  4. Maintain a Defensible Audit Trail
    Businesses should be able to show how the product was classified, which jurisdictional rule was applied, how the tax was calculated, and where the transaction appeared on the return.
  5. Keep Up With Evolving Nicotine Products
    Nicotine analogs won’t be the last product innovation to challenge existing tax definitions. As manufacturers introduce new ingredients, delivery methods, and product formats, businesses need tax processes that can adapt without relying on constant manual research and spreadsheet updates.

IGEN’s tax experts researched how states define and tax nicotine analog products and updated the platform’s determination and reporting content accordingly.

  • IGEN Tax Determination applies expert-maintained product- and jurisdiction-specific rules and rates to calculate excise, sales, and use taxes in real time.
  • IGEN Tax Reporting helps tax teams validate transaction data, assign products to the correct schedules, and generate accurate forms and e-files.

Talk to IGEN about determining and reporting taxes for nicotine analogs and other evolving nicotine products

This analysis is intended for informational purposes only and is not tax advice.  For tax advice, consult your tax adviser. See the full disclaimer here.